Results 81 to 90 of about 14,435 (202)

Utilizing Machine Learning to Predict Liver Allograft Fibrosis by Leveraging Clinical and Imaging Data

Clinical Transplantation, Volume 39, Issue 4, April 2025.
ABSTRACT Background and Aim Liver transplant (LT) recipients may succumb to graft‐related pathologies, contributing to graft fibrosis (GF). Current methods to diagnose GF are limited, ranging from procedural‐related complications to low accuracy. With recent advances in machine learning (ML), we aimed to develop a noninvasive tool using demographic ...
Madhumitha Rabindranath, Yingji Sun, Korosh Khalili, Mamatha Bhat   +3 more
wiley   +1 more source

CYCLOSPORIN A AS A MEANS OF PREVENTING REJECTION OF SKELETAL MUSCLE ALLOGRAFTS IN MICE

, 1981
Diana J. Watt, T. Partridge, J. C. Sloper   +2 more
openalex   +1 more source

Cyclosporin therapy in vivo attenuates the response to vasodilators in the isolated perfused kidney of the rabbit [PDF]

, 1989
Hugh Cairns, Lynette D. Fairbanks, John Westwick, Guy H. Neild   +3 more
openalex   +1 more source

Five‐Year Real‐World Safety of Inotuzumab Ozogamicin Before Hematopoietic Stem Cell Transplantation in B‐Cell Precursor Acute Lymphoblastic Leukemia

American Journal of Hematology, Volume 100, Issue 5, Page 909-912, May 2025.
Marcos de Lima, Partow Kebriaei, Francesco Lanza, Christina Cho, Gizelle Popradi, Manmeet Kaur, Mei‐Jie Zhang, Fan Zhang, Richa Shah, Erik Vandendries, Kofi Asomaning, Stephanie Dorman, Matthias Stelljes, David I. Marks, Wael Saber   +14 more
wiley   +1 more source

New Scenarios in Liver Transplantation for Hepatocellular Carcinoma

Liver International, Volume 45, Issue 4, April 2025.
ABSTRACT Background and Aims Despite liver transplantation (LT) is considered the optimal treatment for hepatocellular carcinoma (HCC), particularly in patients with impaired liver function, the shortage of donors has forced the application of very restrictive criteria for selecting ideal candidates for whom LT can offer the best outcome.
Ezequiel Mauro, Manuel Rodríguez‐Perálvarez, Antonio D'Alessio, Gonzalo Crespo, Federico Piñero, Eleonora De Martin, Jordi Colmenero, David James Pinato, Alejandro Forner   +8 more
wiley   +1 more source

Immunosuppressive therapy for progressive idiopathic membranous nephropathy: a cost-effectiveness analysis in China. [PDF]

BMC Health Serv Res, 2023
Xu W, Zhang Z, Li D, Dai W, Pan C, Guo M, Zhao Y, Cui X.   +7 more
europepmc   +1 more source

Pharmacokinetics of cyclosporin: influence of rate‐duration profile of an intravenous infusion in renal transplant patients. [PDF]

, 1989
SK Gupta, Ali Bakran, Johnson Rw, Malcolm Rowland   +3 more
openalex   +1 more source

A Phase I Trial of the ABCB1 Inhibitor, Oral Valspodar, in Combination With Paclitaxel in Patients With Advanced Solid Tumors. [PDF]

Am J Clin Oncol, 2023
Fracasso PM, Fisher GA, Goodner SA, Beumer JH, Egorin MJ, Fears CL, Wildi JD, Jones GJ, Pearce TE, Sikic BI.   +9 more
europepmc   +1 more source

Overlap syndrome in a 12-year-old girl with systemic lupus erythematosus and anti-oj antibody-positive polymyositis: a case report. [PDF]

Pediatr Rheumatol Online J, 2022
Lin KH, Kao JK.
europepmc   +1 more source

EFFECT OF IN VITRO CYCLOSPORIN A TREATMENT ON HUMAN NATURAL AND ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY

, 1983
Chen Shao-Hsien, István Láng, H Gunn, Peter M. Lydyard   +3 more
openalex   +1 more source